what is nolvadex used for in bodybuilding Given lower response rates, shorter duration of response, and poor survival, TP53 mutated patients do not derive long term benefits from Venetoclax based therapies and should be offered clinical trials whenever feasible

Reviewed by fraweella on April 7, 2023, 2:32 a.m. | Permalink

This review has no votes.